Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist's Perspective

Michael R Rudnick; Ihab M Wahba; Amanda K Leonberg-Yoo

doi:10.34067/KID.0003022020

Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist's Perspective

Kidney360. 2020 Jun 25;1(6):433-435. doi: 10.34067/KID.0003022020.

Authors

Michael R Rudnick¹, Ihab M Wahba^{1

2}, Amanda K Leonberg-Yoo¹

Affiliations

¹ University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
² Philadelphia Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania.

No abstract available

Keywords: chronic kidney disease; clinical nephrology; gadolinium-based contrast agents; magnetic resonance imaging; nephrogenic systemic fibrosis.

Publication types

Editorial
Comment

MeSH terms

Contrast Media* / adverse effects
Gadolinium / adverse effects
Humans
Magnetic Resonance Imaging / adverse effects
Nephrologists
Renal Insufficiency* / chemically induced

Substances

Contrast Media
Gadolinium